We are live on ! Find out more
HAE icon

Haemonetics
HAE

242 hedge funds and large institutions have $3.26B invested in Haemonetics in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 97 increasing their positions, 83 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

97% more call options, than puts

Call options by funds: $3.56M | Put options by funds: $1.81M

23% more capital invested

Capital invested by funds: $2.65B → $3.26B (+$604M)

17% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 83

2.9% more ownership

Funds ownership: 97.99% → 100.9% (+2.9%)

6% less funds holding

Funds holding: 257 → 242 (-15)

33% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 42

Holders
242
Holders Change
-15
Holders Change %
-5.84%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
97
Reduced
83
Closed
42
Calls
$3.56M
Puts
$1.81M
Net Calls
+$1.75M
Net Calls Change
-$10.3M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$185M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$59.4M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$17.4M
4
EA
Emerald Advisers
Pennsylvania
+$14.5M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$12.1M

Top Sellers

1
AC
Armistice Capital
New York
-$46.3M
2
BlackRock
BlackRock
New York
-$40.3M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$40M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$23.6M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
76
UBS AM
Illinois
$3.91M +$22.3K +411 +0.7%
MIM
77
MetLife Investment Management
New Jersey
$3.8M +$935K +17,188 +40%
Nordea Investment Management
78
Nordea Investment Management
Sweden
$3.68M +$37.6K +692 +1%
CS
79
Credit Suisse
Switzerland
$3.3M +$181K +3,322 +7%
New York State Common Retirement Fund
80
New York State Common Retirement Fund
New York
$3.06M +$2.07K +38 +0.1%
MOACM
81
Mutual of America Capital Management
New York
$2.95M +$49.3K +906 +2%
Holocene Advisors
82
Holocene Advisors
New York
$2.88M -$1.34M -24,600 -35%
State of New Jersey Common Pension Fund D
83
State of New Jersey Common Pension Fund D
New Jersey
$2.88M -$245K -4,508 -9%
HSBC Holdings
84
HSBC Holdings
United Kingdom
$2.86M +$824K +15,160 +50%
BC
85
Beaconlight Capital
New York
$2.51M +$2.15M +39,626 New
Victory Capital Management
86
Victory Capital Management
Texas
$2.43M +$1.9M +34,898 +527%
Comerica Bank
87
Comerica Bank
Texas
$2.38M -$3.75M -68,969 -62%
TPSF
88
Texas Permanent School Fund
Texas
$2.29M -$33.1K -609 -2%
BNP Paribas Financial Markets
89
BNP Paribas Financial Markets
France
$2.28M -$2.37M -43,622 -55%
WC
90
Walthausen & Co
New York
$2.21M +$1.9M +35,026 New
AB
91
Amalgamated Bank
New York
$2.15M -$87.2K -1,603 -5%
AF
92
Amalgamated Financial
New York
$2.15M +$1.85M +33,943 New
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$2.03M +$1.35M +24,785 +300%
AIC
94
Aurora Investment Counsel
Georgia
$1.99M -$37.9K -697 -2%
Canada Life
95
Canada Life
Manitoba, Canada
$1.81M +$110K +2,018 +8%
YCM
96
Yousif Capital Management
Michigan
$1.68M +$10.6K +195 +0.7%
AQR Capital Management
97
AQR Capital Management
Connecticut
$1.61M +$1.02M +18,704 +267%
GLA
98
Great Lakes Advisors
Illinois
$1.6M -$154K -2,838 -10%
Envestnet Asset Management
99
Envestnet Asset Management
Illinois
$1.56M +$512K +9,417 +62%
PP
100
PDT Partners
New York
$1.49M +$1.28M +23,553 New
2 3
4
5 6

HAE Hedge Fund Activity: Q1 2022 in Review

242 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2022, worth a combined $3.26B — up 23% from $2.65B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of HAE and 28 opened new positions — a net loss of 14 holders — while 83 trimmed existing stakes and 97 added.

The largest buyer was Capital Research Global Investors, adding an estimated $185M. The largest seller was Armistice Capital, exiting entirely with an estimated $46.3M sold.

  • 242 institutional investors held Haemonetics (HAE) as of Q1 2022, down from 257 in Q4 2021.
  • Funds reported $3.26B of Haemonetics stock for Q1 2022, up 23% quarter-over-quarter.
  • 28 funds opened new Haemonetics positions in Q1 2022 and 42 closed out, a net change of -14 holders.
  • The largest Haemonetics buyer in Q1 2022 was Capital Research Global Investors, an estimated $185M added.
  • The largest Haemonetics seller in Q1 2022 was Armistice Capital, an estimated $46.3M sold.

Based on aggregated 13F filings for Q1 2022.